4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001708138-20-000106
Director sold 6,090 shares at $552.36 ($3,363,872)
- Director acquired 5,090 shares (option exercise)
- Director gave 1,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
BROWN MICHAEL S · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-22 | Exercise or conversion : show line 1 in the form | +2,480 | $380.95 | $944,756 | 3,123 | D |
| 2020-09-22 | Exercise or conversion : show line 2 in the form | +2,610 | $376.69 | $983,161 | 5,733 | D |
| 2020-09-22 | Sale : show line 3 in the form | −5,090 | $552.36 | $2,811,512 | 643 | D |
| 2020-05-13 | Gift : show line 4 in the form | −1,000 | 10,349 | I | ||
| 2020-09-22 | Sale : show line 5 in the form | −1,000 | $552.36 | $552,360 | 9,349 | I |
| Open-market sales · 6,090 sh · avg $552.36 · $3,363,872 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-09-22 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −2,610 | $376.69 | 2027-01-03 | 2,610 | 0 | D |
| 2020-09-22 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | −2,480 | $380.95 | 2028-01-02 | 2,480 | 4,959 | D |
Loading xslF345X03/edgardoc.xml…